Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Infection Reactivation”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Testing effectiveness (Phase 2)UnknownNCT05432778
What this trial is testing

Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients

Who this might be right for
CMV Viremia
University Medical Centre Ljubljana 90
Testing effectiveness (Phase 2)Study completedNCT03067155
What this trial is testing

CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.

Who this might be right for
Hematological MalignanciesCMV Infection
University Hospital, Ghent 1
Testing effectiveness (Phase 2)Study completedNCT04312841
What this trial is testing

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 6
Not applicableUnknownNCT01397058
What this trial is testing

Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress

Who this might be right for
Cytomegalovirus ViraemiaStress, PhysiologicalReceptor, Hormonal; Disorder+1 more
University of Athens 275
Not applicableLooking for participantsNCT06812598
What this trial is testing

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

Who this might be right for
Cytomegalovirus InfectionsCMV
The First Affiliated Hospital of Soochow University 330
Not applicableNo Longer AvailableNCT01945619
What this trial is testing

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)

Who this might be right for
EBV InfectionCMV InfectionAdenoviral Infection
Baylor College of Medicine
Not applicableUnknownNCT06520605
What this trial is testing

Cytomegalovirus Reactivation in ICU Patients Requiring Prolong Mechanical Ventilation

Who this might be right for
Mechanical Ventilation
Sanjay Gandhi Postgraduate Institute of Medical Sciences 125
Not applicableStudy completedNCT00006314
What this trial is testing

Cytomegalovirus Spread and Reactivation in Blood Cells

Who this might be right for
Blood DiseaseCytomegalovirus Infections
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableEnded earlyNCT02843880
What this trial is testing

Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study

Who this might be right for
CMV Infection
AdministrateurDRC 1
Not applicableStudy completedNCT00366717
What this trial is testing

Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy

Who this might be right for
CancerCytomegalovirus
Mackay Memorial Hospital 20
Not applicableEnded earlyNCT03570411
What this trial is testing

Evaluating the Clinical Utility of the T-SPOT.CMV Assay for the Prediction of CMV Reactivation Among Pediatric Patients Undergoing Hematopoietic Cell Transplant

Who this might be right for
CMV
St. Jude Children's Research Hospital 11
Post-approval studies (Phase 4)UnknownNCT05914701
What this trial is testing

Secondary Prophylaxis of CMV Infection Using Letermovir After HID-HSCT

Who this might be right for
To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
Institute of Hematology & Blood Diseases Hospital, China 31
Not applicableStudy completedNCT07621835
What this trial is testing

Risk Factors Associated With the Absence of CMV-specific Cellular Immune Response in the Early Post-transplant Period in Low-risk CMV-seropositive Kidney Transplant Recipients

Who this might be right for
CMV Specific Immune ResponseKidney TransplantKidney Transplant Recipient+1 more
Maimónides Biomedical Research Institute of Córdoba 236
Not applicableLooking for participantsNCT06916195
What this trial is testing

Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus InfectionHematopoietic Stem Cells Transplantation
MSD Italia S.r.l. 230
Testing effectiveness (Phase 2)Looking for participantsNCT02048332
What this trial is testing

Donor-Derived Viral Specific T-cells (VSTs)

Who this might be right for
Allogeneic Stem Cell TransplantViral InfectionViral Reactivation
Children's Hospital Medical Center, Cincinnati 1,000
Not applicableUnknownNCT06374511
What this trial is testing

Prospective Cohort Study of Complications and Outcomes in Cirrhosis

Who this might be right for
Decompensated CirrhosisCMV ReactivationOvert Hepatic Encephalopathy
Nanfang Hospital, Southern Medical University 660
Not applicableLooking for participantsNCT07609576
What this trial is testing

Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.

Who this might be right for
Lymphoma NeoplasmsMyeloma MultipleSevere Infection+3 more
Infanta Leonor University Hospital 350
Large-scale testing (Phase 3)Study completedNCT01077908
What this trial is testing

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study

Who this might be right for
Cytomegalovirus Infection
Cell Medica Ltd 89
Not applicableEnded earlyNCT02873325
What this trial is testing

Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT

Who this might be right for
Infectious Complications Following HSCT
Cell Medica Ltd 1
Early research (Phase 1)WithdrawnNCT05589844
What this trial is testing

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegaloviral InfectionHematopoietic and Lymphoid System Neoplasm
Roswell Park Cancer Institute
Next Page